Acute hyperosmolar hyperglycaemic state in cystic fibrosis-related diabetes caused by glucocorticoid and itraconazole interaction

J Cyst Fibros. 2021 Mar;20(2):330-332. doi: 10.1016/j.jcf.2020.08.018. Epub 2020 Sep 11.

Abstract

Hyperosmolar hyperglycaemic state (HHS) has not previously been reported in cystic fibrosis-related diabetes (CFRD). We report the case of a 15-year old boy with stable CFRD who developed acute HHS after treatment with glucocorticoids and itraconazole for presumed allergic broncho-pulmonary aspergillosis (ABPA). This case highlights the dangerous and preventable combination of high glucose intake, glucocorticoids and itraconazole inhibition of CYP3A4 (with resultant glucocorticoid accumulation) that can result in a state of life- threatening HHS in an adolescent with previously stable CFRD.

Keywords: CFRD; Cystic fibrosis related diabetes; Fluticasone; Glucocorticoid; HHS; HONK; Hyperglycaemic hyperosmolar state; Hyperosmolar non-ketotic coma; Interaction; Itraconazole.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antifungal Agents / adverse effects*
  • Cystic Fibrosis / complications*
  • Diabetes Mellitus, Type 2 / etiology
  • Drug Interactions
  • Glucocorticoids / adverse effects*
  • Humans
  • Hyperglycemic Hyperosmolar Nonketotic Coma / chemically induced*
  • Itraconazole / adverse effects*
  • Male
  • Pulmonary Aspergillosis / drug therapy

Substances

  • Antifungal Agents
  • Glucocorticoids
  • Itraconazole